Human Mycobiome Core - World Map
Spain
| Health status | Core fungal species (>50% prevalence) |
| HC (n=57) | Dacryopinax primogenitus, Saccharomyces cerevisiae |
| CD (n=38) | Saccharomyces cerevisiae |
| UC (n=52) | Saccharomyces cerevisiae |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| HC (n=63) | Flagellar assembly |
| HC (n=63) | RNA polymerase |
| HC (n=63) | Type III secretion system |
| HC (n=63) | ATP synthesis |
| HC (n=63) | Citrate cycle (TCA cycle) |
| HC (n=63) | D.Arginine and D.ornithine metabolism |
| HC (n=63) | Glutamate metabolism |
| HC (n=63) | Glycolysis / Gluconeogenesis |
| HC (n=63) | Lysine degradation |
| HC (n=63) | Purine metabolism |
| HC (n=63) | Pyrimidine metabolism |
| HC (n=63) | Pyruvate metabolism |
| HC (n=63) | unknown_pathway_class |
| CD (n=50) | Flagellar assembly |
| CD (n=50) | RNA polymerase |
| CD (n=50) | Type III secretion system |
| CD (n=50) | ATP synthesis |
| CD (n=50) | Glycolysis / Gluconeogenesis |
| CD (n=50) | Lysine degradation |
| CD (n=50) | Pentose and glucuronate interconversions |
| CD (n=50) | Purine metabolism |
| CD (n=50) | Pyrimidine metabolism |
| CD (n=50) | unknown_pathway_class |
| UC (n=69) | Flagellar assembly |
| UC (n=69) | RNA polymerase |
| UC (n=69) | Type III secretion system |
| UC (n=69) | ATP synthesis |
| UC (n=69) | Carbon fixation |
| UC (n=69) | Citrate cycle (TCA cycle) |
| UC (n=69) | D.Arginine and D.ornithine metabolism |
| UC (n=69) | Glutamate metabolism |
| UC (n=69) | Glycolysis / Gluconeogenesis |
| UC (n=69) | Lysine degradation |
| UC (n=69) | Pentose and glucuronate interconversions |
| UC (n=69) | Purine metabolism |
| UC (n=69) | Pyrimidine metabolism |
| UC (n=69) | Pyruvate metabolism |
France
| Health status | Core fungal species (>50% prevalence) |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
Belgium
| Health status | Core fungal species (>50% prevalence) |
| CD (n=76) | Aspergillus recurvatus, Saccharomyces cerevisiae |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| CD (n=92) | Purine metabolism |
Italy
| Health status | Core fungal species (>50% prevalence) |
| INFANT (n=14) | Malassezia globosa, Malassezia restricta , uncultured Malassezia |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| INFANT (n=17) | Purine metabolism |
| INFANT (n=17) | Pyrimidine metabolism |
| INFANT (n=17) | unknown_pathway_class |
| HC (n=7) | Purine metabolism |
| HC (n=7) | Pyrimidine metabolism |
| HC (n=7) | Pyruvate metabolism |
| HC (n=7) | Citrate cycle (TCA cycle) |
| HC (n=7) | Glycolysis / Gluconeogenesis |
| HC (n=7) | Carbon fixation |
| HC (n=7) | D.Arginine and D.ornithine metabolism |
| HC (n=7) | RNA polymerase |
| HC (n=7) | Selenoamino acid metabolism |
| HC (n=7) | Sulfur metabolism |
| HC (n=7) | unknown_pathway_class |
| HC (n=7) | Flagellar assembly |
| HC (n=7) | Type III secretion system |
| HC (n=7) | ATP synthesis |
| HC (n=7) | Lysine degradation |
Argentina
| Health status | Core fungal species (>50% prevalence) |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
Denmark
| Health status | Core fungal species (>50% prevalence) |
| HC (n=118) | Saccharomyces cerevisiae |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| HC (n=164) | RNA polymerase |
| HC (n=164) | Glycolysis / Gluconeogenesis |
| HC (n=164) | Lysine degradation |
| HC (n=164) | Purine metabolism |
| HC (n=164) | Pyrimidine metabolism |
| HC (n=164) | Pyruvate metabolism |
| HC (n=164) | unknown_pathway_class |
Canada
| Health status | Core fungal species (>50% prevalence) |
| PLWH (n=7) | Saccharomyces cerevisiae |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| PLWH (n=10) | Flagellar assembly |
| PLWH (n=10) | RNA polymerase |
| PLWH (n=10) | Type III secretion system |
| PLWH (n=10) | ATP synthesis |
| PLWH (n=10) | Carbon fixation |
| PLWH (n=10) | Citrate cycle (TCA cycle) |
| PLWH (n=10) | D.Arginine and D.ornithine metabolism |
| PLWH (n=10) | Glutamate metabolism |
| PLWH (n=10) | Glycolysis / Gluconeogenesis |
| PLWH (n=10) | Purine metabolism |
| PLWH (n=10) | Pyrimidine metabolism |
| PLWH (n=10) | Pyruvate metabolism |
USA
| Health status | Core fungal species (>50% prevalence) |
| PSO (n=16) | Saccharomyces cerevisiae |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| PSO (n=24) | Flagellar assembly |
| PSO (n=24) | RNA polymerase |
| PSO (n=24) | Type III secretion system |
| PSO (n=24) | ATP synthesis |
| PSO (n=24) | Carbon fixation |
| PSO (n=24) | Citrate cycle (TCA cycle) |
| PSO (n=24) | Glycolysis / Gluconeogenesis |
| PSO (n=24) | Purine metabolism |
| PSO (n=24) | Pyrimidine metabolism |
| PSO (n=24) | Pyruvate metabolism |
| PSO (n=24) | unknown_pathway_class |
| CD (n=13) | Purine metabolism |
| CD (n=13) | Pyruvate metabolism |
| CD (n=13) | unknown_pathway_class |
| UC (n=10) | Flagellar assembly |
| UC (n=10) | RNA polymerase |
| UC (n=10) | Type III secretion system |
| UC (n=10) | ATP synthesis |
| UC (n=10) | Carbon fixation |
| UC (n=10) | Citrate cycle (TCA cycle) |
| UC (n=10) | Glycolysis / Gluconeogenesis |
| UC (n=10) | Purine metabolism |
| UC (n=10) | Pyrimidine metabolism |
| UC (n=10) | Pyruvate metabolism |
| UC (n=10) | unknown_pathway_class |
| HC (n=12) | Purine metabolism |
| HC (n=12) | unknown_pathway_class |
| HC (n=12) | Pyruvate metabolism |
| HC (n=12) | Citrate cycle (TCA cycle) |
| HC (n=12) | Carbon fixation |
| HC (n=12) | Glycolysis / Gluconeogenesis |
| HC (n=12) | D.Arginine and D.ornithine metabolism |
| HC (n=12) | Pyrimidine metabolism |
| HC (n=12) | Flagellar assembly |
| HC (n=12) | Type III secretion system |
| HC (n=12) | ATP synthesis |
| HC (n=12) | RNA polymerase |
| HC (n=12) | Pentose and glucuronate interconversions |
| HIV (n=6) | Purine metabolism |
| HIV (n=6) | Purine metabolism |
| Preterm (n=140) | Purine metabolism |
| Preterm (n=140) | Pyrimidine metabolism |
| Preterm (n=140) | unknown_pathway_class |
China
| Health status | Core fungal species (>50% prevalence) |
| ESRD (n=106) | Yarrowia lipolytica |
| T2D (n=49) | Saccharomyces cerevisiae |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| ESRD (n=208) | Glycolysis / Gluconeogenesis |
| ESRD (n=208) | Purine metabolism |
| ESRD (n=208) | Pyrimidine metabolism |
| ESRD (n=208) | Pyruvate metabolism |
| ESRD (n=208) | unknown_pathway_class |
| T2D (n=89) | Glycolysis / Gluconeogenesis |
| T2D (n=89) | Lysine degradation |
| T2D (n=89) | Pentose and glucuronate interconversions |
| T2D (n=89) | Purine metabolism |
| T2D (n=89) | Pyrimidine metabolism |
| T2D (n=89) | Pyruvate metabolism |
| T2D (n=89) | unknown_pathway_class |
| HC (n=301) | Purine metabolism |
| HC (n=301) | unknown_pathway_class |
| CD (n=38) (>97%) | RNA polymerase |
| CD (n=38) (>97%) | Pentose and glucuronate interconversions |
| CD (n=38) (>97%) | Purine metabolism |
| CD (n=38) (>97%) | Pyrimidine metabolism |
| CD (n=38) (>97%) | unknown_pathway_class |
Australia
| Health status | Core fungal species (>50% prevalence) |
| HC (n=46) | Aspergillus recurvatus |
| T1D (n=40) | Aspergillus recurvatus |
| Health status | Core fungal pathways (>99% prevalence & >0.1% abundance) |
| HC (n=56) | Carbon fixation |
| HC (n=56) | Citrate cycle (TCA cycle) |
| HC (n=56) | D.Arginine and D.ornithine metabolism |
| HC (n=56) | Glycolysis / Gluconeogenesis |
| HC (n=56) | Pentose and glucuronate interconversions |
| HC (n=56) | Purine metabolism |
| HC (n=56) | Pyruvate metabolism |
| T1D (n=60) | Citrate cycle (TCA cycle) |
| T1D (n=60) | Fructose and mannose metabolism |
| T1D (n=60) | Pentose and glucuronate interconversions |
| T1D (n=60) | Purine metabolism |
| T1D (n=60) | Pyruvate metabolism |